Financial results - ENDOCRINE. RO SRL

Financial Summary - Endocrine. Ro Srl
Unique identification code: 35542110
Registration number: J16/192/2016
Nace: 8622
Sales - Ron
120.289
Net Profit - Ron
77.548
Employee
3
The most important financial indicators for the company Endocrine. Ro Srl - Unique Identification Number 35542110: sales in 2023 was 120.289 euro, registering a net profit of 77.548 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Endocrine. Ro Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 33.653 41.951 43.740 46.258 76.260 95.086 103.402 120.289
Total Income - EUR - - 33.653 41.951 43.740 46.258 76.260 95.087 103.403 120.290
Total Expenses - EUR - - 157 85 370 878 28.374 31.631 37.342 41.539
Gross Profit/Loss - EUR - - 33.495 41.866 43.370 45.380 47.887 63.456 66.061 78.751
Net Profit/Loss - EUR - - 32.486 40.607 42.057 43.992 47.124 62.505 65.027 77.548
Employees - - 0 0 0 0 0 0 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 16.7%, from 103.402 euro in the year 2022, to 120.289 euro in 2023. The Net Profit increased by 12.718 euro, from 65.027 euro in 2022, to 77.548 in the last year.

Check the financial reports for the company - Endocrine. Ro Srl

Rating financiar

Financial Rating -
Endocrine. Ro Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Endocrine. Ro Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Endocrine. Ro Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Endocrine. Ro Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Endocrine. Ro Srl - CUI 35542110

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 0 0 0 0 0 0 0 0
Current Assets - - 32.765 40.958 42.351 44.431 49.783 65.247 70.410 81.309
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 0 0 519 25.052 34.443 28.938 49.499 78.363
Cash - - 32.765 40.958 41.832 19.379 15.340 36.309 20.911 2.946
Shareholders Funds - - 32.530 40.660 42.109 44.043 47.174 62.554 65.076 77.596
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 235 298 243 389 2.609 2.693 5.334 3.713
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 81.309 euro in 2023 which includes Inventories of 0 euro, Receivables of 78.363 euro and cash availability of 2.946 euro.
The company's Equity was valued at 77.596 euro, while total Liabilities amounted to 3.713 euro. Equity increased by 12.718 euro, from 65.076 euro in 2022, to 77.596 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Endocrine. Ro Srl

Comments - Endocrine. Ro Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.